FibroGen (NASDAQ:FGEN) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded shares of FibroGen (NASDAQ:FGEN – Free Report) to a hold rating in a research note issued to investors on Saturday. Other research analysts have also issued reports about the company. William Blair reaffirmed a “market perform” rating on shares of FibroGen in a report on Tuesday, April 1st. HC Wainwright reissued […]
Wall Street Zen upgraded shares of FibroGen (NASDAQ:FGEN – Free Report) to a hold rating in a research note issued to investors on Saturday. Other research analysts have also issued reports about the company. William Blair reaffirmed a “market perform” rating on shares of FibroGen in a report on Tuesday, April 1st. HC Wainwright reissued […]
